Evidence map›Paper›PMID 29610560›Full record

ArticleJournal of clinical biochemistry and nutrition2018

Early diagnosis of type 2 diabetes based on multiple biomarkers and non-invasive indices.

Aya Umeno, Toshiki Fukui, Yoshiko Hashimoto, Masatoshi Kataoka, Yoshihisa Hagihara, Hidenori Nagai, Masanori Horie, Mototada Shichiri, Kohzoh Yoshino, Yasukazu Yoshida

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical biochemistry and nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Significance of Singlet Oxygen Molecule in Pathologies.International journal of molecular sciences · 2023
    Review
  2. Review
  3. Review of methods for detecting glycemic disorders.Diabetes research and clinical practice · 2020
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Aya UmenoHealth Research Institute, National Institute of Advanced Industrial Science and Technology, 2217-14 Hayashi-cho, Takamatsu, Kagawa 761-0395, Japan.
Toshiki FukuiOlive Takamatsu Medical Clinic. 649-8 Kankou-cho, Takamatsu, Kagawa 760-0076, Japan.
Yoshiko HashimotoHealth Research Institute, National Institute of Advanced Industrial Science and Technology, 2217-14 Hayashi-cho, Takamatsu, Kagawa 761-0395, Japan.
Masatoshi KataokaHealth Research Institute, National Institute of Advanced Industrial Science and Technology, 2217-14 Hayashi-cho, Takamatsu, Kagawa 761-0395, Japan.
Yoshihisa HagiharaBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology, 1-8-31 Midorigaoka. Ikeda, Osaka 563-8577, Japan.
Hidenori NagaiBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology, 1-8-31 Midorigaoka. Ikeda, Osaka 563-8577, Japan.
Masanori HorieHealth Research Institute, National Institute of Advanced Industrial Science and Technology, 2217-14 Hayashi-cho, Takamatsu, Kagawa 761-0395, Japan.
Mototada ShichiriBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology, 1-8-31 Midorigaoka. Ikeda, Osaka 563-8577, Japan.
Kohzoh YoshinoSchool of Science and Technology, Kwansei Gakuin University, 2-1 Shigakuen, Sanda, Hyogo 669-1337, Japan.
Yasukazu YoshidaHealth Research Institute, National Institute of Advanced Industrial Science and Technology, 2217-14 Hayashi-cho, Takamatsu, Kagawa 761-0395, Japan.
National Institute of Advanced Industrial Science and Technology · JPBiomedical Research Institute · USKwansei Gakuin University · JPNational Hospital Organization Takamatsu Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported that type 2 diabetes risk, early impaired glucose tolerance and insulin resistance can be predicted by measuring the fasting levels of certain biomarkers. Here we validated these findings in randomly recruited healthy volunteers (

Indexed as

biomarkerdiabetesearly detectionimpaired glucose toleranceoxidative stress

Identifiers

PMID29610560
PMCPMC5874237
OpenAlexW2778527626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.